English (United Kingdom)French (Fr)

FDA Warning on Drugs for ADHD

Thursday, 01 September 2005 00:00

The FDA is requiring new labeling changes for stimulant drugs used to treat ADHD. Most, it appears, are variations on methylphenidate (Ritalin, Concerta, etc.). The drugs have produced side-effects including, according to the FDA, events such as visual hallucinations, suicidal ideation, psychotic behavior, as well as aggression or violent behavior. The FDA is seeking the panel’s advice on what information it should provide to the public about the ADHD drugs that are widely used in children while it’s collecting information on the number of types of psychiatric events possibly associated with ADHD drugs along with possible cardiovascular risks.

FDA Warning on Drugs for ADHDThe FDA is concerned with possible cardiovascular events in people using the drugs. Earlier this year Health Canada ordered Adderall off the market after reports of sudden death in 20 patients, including 12 reports of stroke.

Some ADHD drugs are now being implicated as possible causes for liver cancer. Scientists report that incidents of liver cancer in children have roughly doubled over the past two decades.

Pathways Issue 7 CoverThis article appeared in Pathways to Family Wellness magazine, Issue #07.

To purchase this issue, Order Here.